Genprex
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Genprex and other ETFs, options, and stocks.About GNPX
Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company product is REQORSA immunogen therapy drug for non-small cell lung cancer.
CEORyan M. Confer
CEORyan M. Confer
Employees15
Employees15
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded2009
Founded2009
Employees15
Employees15
GNPX Key Statistics
Market cap6.86M
Market cap6.86M
Price-Earnings ratio-0.04
Price-Earnings ratio-0.04
Dividend yield—
Dividend yield—
Average volume700.58K
Average volume700.58K
High today$4.98
High today$4.98
Low today$4.16
Low today$4.16
Open price$4.71
Open price$4.71
Volume230.57K
Volume230.57K
52 Week high$117.50
52 Week high$117.50
52 Week low$4.16
52 Week low$4.16
Stock Snapshot
Genprex(GNPX) stock is priced at $4.38, giving the company a market capitalization of 6.86M. It carries a P/E multiple of -0.04.
On 2025-11-08, Genprex(GNPX) stock traded between a low of $4.16 and a high of $4.98. Shares are currently priced at $4.38, which is +5.3% above the low and -12.0% below the high.
Genprex(GNPX) shares are trading with a volume of 230.57K, against a daily average of 700.58K.
During the past year, Genprex(GNPX) stock moved between $4.16 at its lowest and $117.50 at its peak.
During the past year, Genprex(GNPX) stock moved between $4.16 at its lowest and $117.50 at its peak.
People also own
Based on the portfolios of people who own GNPX. This list is generated using Robinhood data, and it’s not a recommendation.